These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 31655118)

  • 1. The mutational landscape of mucosal melanoma.
    Nassar KW; Tan AC
    Semin Cancer Biol; 2020 Apr; 61():139-148. PubMed ID: 31655118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
    Hintzsche JD; Gorden NT; Amato CM; Kim J; Wuensch KE; Robinson SE; Applegate AJ; Couts KL; Medina TM; Wells KR; Wisell JA; McCarter MD; Box NF; Shellman YG; Gonzalez RC; Lewis KD; Tentler JJ; Tan AC; Robinson WA
    Melanoma Res; 2017 Jun; 27(3):189-199. PubMed ID: 28296713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominance of triple wild-type and IGF2R mutations in mucosal melanomas.
    Iida Y; Salomon MP; Hata K; Tran K; Ohe S; Griffiths CF; Hsu SC; Nelson N; Hoon DSB
    BMC Cancer; 2018 Oct; 18(1):1054. PubMed ID: 30373548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade.
    Buchbinder EI; Weirather JL; Manos M; Quattrochi BJ; Sholl LM; Brennick RC; Bowling P; Bailey N; Magarace L; Ott PA; Haq R; Izar B; Giobbie-Hurder A; Hodi FS
    Cancer Med; 2021 Apr; 10(8):2627-2635. PubMed ID: 33724703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing of oral mucosal melanoma reveals mutational profile and therapeutic targets.
    Lyu J; Song Z; Chen J; Shepard MJ; Song H; Ren G; Li Z; Guo W; Zhuang Z; Shi Y
    J Pathol; 2018 Mar; 244(3):358-366. PubMed ID: 29230811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.
    Newell F; Kong Y; Wilmott JS; Johansson PA; Ferguson PM; Cui C; Li Z; Kazakoff SH; Burke H; Dodds TJ; Patch AM; Nones K; Tembe V; Shang P; van der Weyden L; Wong K; Holmes O; Lo S; Leonard C; Wood S; Xu Q; Rawson RV; Mukhopadhyay P; Dummer R; Levesque MP; Jönsson G; Wang X; Yeh I; Wu H; Joseph N; Bastian BC; Long GV; Spillane AJ; Shannon KF; Thompson JF; Saw RPM; Adams DJ; Si L; Pearson JV; Hayward NK; Waddell N; Mann GJ; Guo J; Scolyer RA
    Nat Commun; 2019 Jul; 10(1):3163. PubMed ID: 31320640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma.
    Broit N; Johansson PA; Rodgers CB; Walpole ST; Newell F; Hayward NK; Pritchard AL
    Mol Cancer Res; 2021 Jun; 19(6):991-1004. PubMed ID: 33707307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
    Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
    Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
    Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
    Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
    Kim HS; Jung M; Kang HN; Kim H; Park CW; Kim SM; Shin SJ; Kim SH; Kim SG; Kim EK; Yun MR; Zheng Z; Chung KY; Greenbowe J; Ali SM; Kim TM; Cho BC
    Oncogene; 2017 Jun; 36(23):3334-3345. PubMed ID: 28092667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Genomic Profiling of Acral Melanoma.
    Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
    J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal Melanoma: A Review Emphasizing the Molecular Landscape and Implications for Diagnosis and Management.
    Rawson RV; Wilmott JS; Scolyer RA
    Surg Pathol Clin; 2021 Jun; 14(2):293-307. PubMed ID: 34023107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Markers and Targets in Melanoma.
    Teixido C; Castillo P; Martinez-Vila C; Arance A; Alos L
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
    Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
    [No Abstract]   [Full Text] [Related]  

  • 16. SF3B1, NRAS, KIT, and BRAF Mutation; CD117 and cMYC Expression; and Tumoral Pigmentation in Sinonasal Melanomas: An Analysis With Newly Found Molecular Alterations and Some Population-Based Molecular Differences.
    Wroblewska JP; Mull J; Wu CL; Fujimoto M; Ogawa T; Marszalek A; Hoang MP
    Am J Surg Pathol; 2019 Feb; 43(2):168-177. PubMed ID: 30273197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of molecular and histopathologic features and expression of PRAME by immunohistochemistry in mucosal melanomas.
    Toyama A; Siegel L; Nelson AC; Najmuddin M; Bu L; LaRue R; Henzler C; Caicedo-Granados E; Giubellino A; Li F
    Mod Pathol; 2019 Dec; 32(12):1727-1733. PubMed ID: 31375769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Roles of
    Wróblewska JP; Dias-Santagata D; Ustaszewski A; Wu CL; Fujimoto M; Selim MA; Biernat W; Ryś J; Marszalek A; Hoang MP
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal melanomas harbor frequent NRAS mutations unlike melanomas of other mucosal sites.
    Sekine S; Nakanishi Y; Ogawa R; Kouda S; Kanai Y
    Virchows Arch; 2009 May; 454(5):513-7. PubMed ID: 19319568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.
    Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP
    BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.